Rehmann Capital Advisory Group Sells 1,614 Shares of Danaher Corporation $DHR

Rehmann Capital Advisory Group decreased its position in shares of Danaher Corporation (NYSE:DHR) by 25.7% during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,666 shares of the conglomerate’s stock after selling 1,614 shares during the period. Rehmann Capital Advisory Group’s holdings in Danaher were worth $922,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also bought and sold shares of the company. MGO One Seven LLC grew its holdings in shares of Danaher by 485.7% in the first quarter. MGO One Seven LLC now owns 25,098 shares of the conglomerate’s stock worth $5,145,000 after purchasing an additional 20,813 shares during the last quarter. Chicago Capital LLC grew its holdings in shares of Danaher by 11.6% in the second quarter. Chicago Capital LLC now owns 13,332 shares of the conglomerate’s stock worth $2,634,000 after purchasing an additional 1,391 shares during the last quarter. UniSuper Management Pty Ltd grew its holdings in shares of Danaher by 1.6% in the first quarter. UniSuper Management Pty Ltd now owns 170,505 shares of the conglomerate’s stock worth $34,954,000 after purchasing an additional 2,667 shares during the last quarter. Asahi Life Asset Management CO. LTD. bought a new position in shares of Danaher in the first quarter worth about $539,000. Finally, Horizon Financial Services LLC grew its holdings in shares of Danaher by 20,400.0% in the first quarter. Horizon Financial Services LLC now owns 8,200 shares of the conglomerate’s stock worth $1,681,000 after purchasing an additional 8,160 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

Insider Activity at Danaher

In related news, Director Teri List sold 2,778 shares of the stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the transaction, the director owned 20,751 shares in the company, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 11.10% of the stock is owned by insiders.

Danaher Stock Performance

Shares of Danaher stock opened at $218.06 on Thursday. The firm has a market capitalization of $156.14 billion, a P/E ratio of 44.96, a PEG ratio of 3.20 and a beta of 0.77. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. The company has a 50 day moving average price of $202.24 and a 200 day moving average price of $197.73. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $260.88.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, October 21st. The conglomerate reported $1.89 EPS for the quarter, beating the consensus estimate of $1.72 by $0.17. The firm had revenue of $6.05 billion during the quarter, compared to analyst estimates of $6 billion. Danaher had a net margin of 14.44% and a return on equity of 10.93%. Danaher’s revenue was up 4.4% on a year-over-year basis. During the same period last year, the firm posted $1.71 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Sell-side analysts expect that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be given a $0.32 dividend. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend is Friday, September 26th. Danaher’s dividend payout ratio (DPR) is presently 27.23%.

Analysts Set New Price Targets

A number of research analysts have recently commented on the stock. Royal Bank Of Canada set a $241.00 price target on shares of Danaher in a report on Tuesday, September 2nd. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Danaher in a research note on Wednesday, October 8th. Barclays upped their price objective on shares of Danaher from $225.00 to $250.00 and gave the stock an “overweight” rating in a research note on Wednesday. Bank of America lowered their price objective on shares of Danaher from $230.00 to $220.00 and set a “buy” rating for the company in a research note on Monday, September 22nd. Finally, Guggenheim reaffirmed a “buy” rating and issued a $250.00 price objective on shares of Danaher in a research note on Wednesday, July 23rd. Seventeen equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $243.39.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.